4//SEC Filing
HANSON GREGORY P 4
Accession 0001415889-18-000311
CIK 0001109196other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 3:48 PM ET
Size
5.8 KB
Accession
0001415889-18-000311
Insider Transaction Report
Form 4
HANSON GREGORY P
Chief Financial Officer
Transactions
- Award
Option to Purchase Common Stock
2018-02-21+195,000→ 195,000 totalExercise: $2.04Exp: 2028-02-21→ Common Stock (195,000 underlying)
Footnotes (2)
- [F1]Option award is partial compensation for service as an officer.
- [F2]The Option Shares shall vest 25% at the 6-month anniversary of the commencement date; with the balance vesting in equal monthly amounts of 4.167% per month over the remaining 18 months until fully vested after 2 years from the commencement date.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeother
Related Parties
1- filerCIK 0001186120
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 3:48 PM ET
- Size
- 5.8 KB